Archives
|
Entry
|
Blogger
|
Date
▴
|
Xconomist
|
Location
|
|
Follica’s Fortunes Growing, Icahn’s Biogen Holdings Mounting, Genzyme’s Mipomersen Work Progressing, & More Life Sciences News
|
Rebecca Zacks |
08/13/08 |
|
|
|
Icahn Ups Biogen Idec Stake to 6 Percent—Bought Big on Tysabri Woes
|
Ryan McBride |
08/12/08 |
|
|
|
Icahn’s Nominee to Yahoo’s Board Winds up on Biogen Idec’s, Epix CEO Steps Down, Caliper Comes to Drugs’ Rescue, & More Life Sciences News
|
Rebecca Zacks |
07/30/08 |
|
|
|
Biogen Idec Adds New Board Member: Another Line of Defense From Icahn?
|
Luke Timmerman |
07/25/08 |
|
|
|
Biogen Idec Isn’t Sweating Possible Sale of Genentech to Roche
|
Luke Timmerman |
07/22/08 |
|
|
|
Icahn and Ballmer Strengthen Case for a Microsoft Takeover of Yahoo, but Lose Some Respect
|
Gregory T. Huang |
07/08/08 |
|
|
|
Health 2.0 Firms in the Spotlight, Biogen Board in the Clear, Alnylam in Asia, & More Life Sciences News
|
Rebecca Zacks |
06/25/08 |
|
|
|
Icahn Nominee Concedes Defeat at Biogen Idec Annual Meeting
|
Robert Buderi |
06/19/08 |
|
|
|
Icahn Nominee to Biogen Idec Board Pledges to Work With Current Management to Restore Research Operations to Past Greatness
|
Robert Buderi |
06/18/08 |
|
|
|
Biogen Directors Win Backing From Third Advisory Firm, Icahn Could Be Heading For Defeat
|
Luke Timmerman |
06/12/08 |
|
|
|
Vertex Moves Hepatitis Drug Forward, Merrimack Rakes in $60M, Biogen and Icahn Trade Barbs, & More Life Sciences News
|
Rebecca Zacks |
06/12/08 |
|
|
|
Do Takeover Efforts (Like Icahn’s Move on Biogen Idec) Harm Innovation?
|
Luke Timmerman |
06/10/08 |
|
|
|
Icahn Has Ideas For Biogen. Starting With More R&D Spending
|
Luke Timmerman |
06/09/08 |
|
|
|
Icahn Jabs Biogen Idec, Says Its Board Had `Very Little’ Input in Sale Process
|
Luke Timmerman |
06/05/08 |
|
|
|
Takeda and Alnylam Join Forces, Carl Icahn Makes His Case, New England Biotech is Hot (Duh), & More Life Sciences News
|
Rebecca Zacks |
05/29/08 |
|
|
|
No Quick Sale, Icahn Says in Letter to Biogen Idec Shareholders
|
Luke Timmerman |
05/28/08 |
|
|
|
BSX Meets With Much Approval, Biogen and Icahn Set the (Showdown) Date, Fate’s Fate Revealed, Win Free Stuff, & More Life Sciences News
|
Rebecca Zacks |
05/14/08 |
|
|
|
Biogen Idec Sets Date for Showdown With Icahn, Proxy Battle Begins
|
Robert Buderi |
05/09/08 |
|
|
|
GSK Takes Sirtris and Taps Alnylam Venture, FDA Deals Genzyme Drug a Blow, Resolvyx Finances Fish-Oil Drugs, & More Life Sciences News
|
Rebecca Zacks |
04/23/08 |
|
|
|
Biogen Idec Announces Its Own Director Slate—Digs in Against Icahn
|
Robert Buderi |
04/17/08 |
|
|
|
A Lawsuit for Biogen, A Suitor for Millennium, The Suits Who Made Their Own Fate, & More Life Sciences News
|
Rebecca Zacks |
04/16/08 |
|
|
|
Icahn Turns Up Heat, Files Suit to Force Biogen Idec to Turn Over Records of Failed Sale
|
Robert Buderi |
04/09/08 |
|
|
|
Exact Sciences Puts Itself on the Block After Investor’s Prodding
|
Rebecca Zacks |
03/18/08 |
|
|
|
Biogen Bouncing Back From Tysabri Warning News
|
Rebecca Zacks |
02/28/08 |
|
|
|
Fearing Icahn’s Impact on Morale, Biogen Idec Launches Key Employee Retention Plan
|
Robert Buderi |
02/15/08 |
|
|
|
Icahn Dumps Genzyme Position
|
Robert Buderi |
02/14/08 |
|
|
|
Barbs of Wisdom: Carl Icahn to Start Blogging
|
Robert Buderi |
02/06/08 |
|
|
|
An Analysis of Icahn’s Biogen Idec Strategy: Why Three Board Seats When Four Will Be Open?
|
Robert Buderi |
01/31/08 |
|
|
|
MIT Teams With Italian Energy Giant, Elixir Postpones Its IPO, Biogen Idec Will Buy or Be Bought, & More
|
Rebecca Zacks |
01/23/08 |
|
|
|
Perceived Risk, Culture Clash Did in Biogen Idec Sale, CEO Asserts
|
Henry Johnson |
01/11/08 |
|
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
